Items where authors include "Petersenn, S."

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 5.

Article

Newell-Price, J., Pivonello, R., Tabarin, A. et al. (9 more authors) (2020) Use of late-night salivary cortisol to monitor response to medical treatment in Cushing’s disease. European Journal of Endocrinology, 182 (2). pp. 207-217. ISSN 0804-4643

Fleseriu, M., Petersenn, S., Biller, B.M.K. et al. (9 more authors) (2019) Long‐term efficacy and safety of once‐monthly pasireotide in Cushing's disease: A Phase III extension study. Clinical Endocrinology, 91 (6). pp. 776-785. ISSN 0300-0664

Lacroix, A., Gu, F., Gallardo, W. et al. (12 more authors) (2018) Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial. The Lancet Diabetes and Endocrinology, 6 (1). pp. 17-26. ISSN 2213-8587

Findling, J.W., Fleseriu, M., Newell-Price, J. et al. (5 more authors) (2016) Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing’s disease: 12-month, Phase III pasireotide study. Endocrine, 54 (2). pp. 516-523. ISSN 1355-008X

Petersenn, S., Newell-Price, J., Findling, J. W. et al. (7 more authors) (2014) High variability in baseline urinary free cortisol values in patients with Cushing's disease. Clinical Endocrinology, 80 (2). pp. 261-269. ISSN 0300-0664

This list was generated on Sun Mar 24 13:04:29 2024 GMT.